Portfolio Company · Operating Co.

CellCore Biosciences

Not on record

backed byKainos Capital

Current

a portfolio company of

Kainos Capital

Status on record: Current

PE Firm Index

Who owns CellCore Biosciences?

CellCore Biosciences is listed as a current portfolio company of Kainos Capital on Kainos Capital's own portfolio page.

Company Snapshot

CellCore Biosciences' owner on record, Kainos Capital, is a middle-market private equity firm headquartered in Dallas. Kainos Capital lists at least 22 companies in the index.

SectorNot on record

Parent PE firmKainos Capital

Ownership statusCurrent

WebsiteNot on record

About the owner

Kainos Capital

Headquarters: Dallas
Strategy: middle-market private equity, control investments, operational improvement, Change Capital
Sectors: non-discretionary food, consumer products and services
Companies in the index: At least 22

Kainos Capital is a Dallas-based middle-market private equity firm that makes control investments in growing businesses.

Read the Kainos Capital profile

Questions about CellCore Biosciences

Who owns CellCore Biosciences?

CellCore Biosciences is listed as a current portfolio company of Kainos Capital on Kainos Capital's own portfolio page.

Where is Kainos Capital headquartered?

Kainos Capital is headquartered in Dallas.

Sources

Kainos Capital
https://kainoscapital.com/portfolio/

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with CellCore Biosciences and does not provide investment advice.

Other portfolio companies of Kainos Capital

6 of 21 shown

Beauty Biosciences, LLC

Colorado Premium

Country Fresh, LLC

Evriholder Products, LLC

Fempro Consumer Products ULC

Ferraro Foods

See the full Kainos Capital portfolio.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Kainos Capital

Dallas

Status: Current

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.